Correlation Engine 2.0
Clear Search sequence regions

  • austria (1)
  • dependent (1)
  • heart (7)
  • heart valves (1)
  • humans (1)
  • patients (4)
  • prosthesis (2)
  • vitamin k (2)
  • Sizes of these terms reflect their relevance to your search.

    In patients after mechanical heart valve replacement anticoagulation is required for the prevention of thrombotic and thromboembolic events. In this setting oral anticoagulation can only be performed with vitamin K antagonists (VKA), while currently all available non-vitamin K dependent oral anticoagulants (NOAC) are contraindicated in patients with mechanical heart valve replacement. This review deals with anticoagulation in patients with mechanical heart valve replacement as well as coagulation inhibition after bioprosthetic or percutaneous valve replacement. In addition, recommendations are given for antithrombotic medication in patients with mechanical heart valve replacement in various clinical scenarios. © 2021. Springer-Verlag GmbH Austria, ein Teil von Springer Nature.


    Frederik Voss, Christoph Sucker, Jens Litmathe. Anticoagulation after heart valve replacement]. Wiener medizinische Wochenschrift (1946). 2023 Mar;173(3-4):84-89

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33950320

    View Full Text